press release – price-sensitive

PRICE-SENSITIVE | NON PRICE-SENSITIVE

  • TURNOVER AS OF MARCH 31, 2025 EQUAL TO APPROXIMATELY 1.3 MILLION EUROS

    TURNOVER AS OF MARCH 31, 2025 EQUAL TO APPROXIMATELY 1.3 MILLION EUROS
    Go to the press release

  • SHAREHOLDERS’ MEETING OF ARTERRA BIOSCIENCE S.P.A.

    SHAREHOLDERS' MEETING OF ARTERRA BIOSCIENCE S.P.A.
    Go to the press release

  • SUBMISSION AND PUBLICATION OF THE LISTS FOR THE APPOINTMENT OF THE MEMBERS OF THE BOARD OF DIRECTORS AND THE BOARD OF STATUTORY AUDITORS

    SUBMISSION AND PUBLICATION OF THE LISTS FOR THE APPOINTMENT OF THE MEMBERS OF THE BOARD OF DIRECTORS AND THE BOARD…
    Go to the press release

  • PUBLICATION OF NOTICE OF CALL FOR ORDINARY SHAREHOLDERS’ MEETING

    PUBLICATION OF NOTICE OF CALL FOR ORDINARY SHAREHOLDERS’ MEETING
    Go to the press release

  • SUBSTANTIAL CHANGE IN OWNERSHIP STRUCTURE

    SUBSTANTIAL CHANGE IN OWNERSHIP STRUCTURE
    Go to the press release

  • THE BOARD OF DIRECTORS HAS APPROVED THE DRAFT FINANCIAL STATEMENTS AS OF 31 DECEMBER 2024

    THE BOARD OF DIRECTORS HAS APPROVED THE DRAFT FINANCIAL STATEMENTS AS OF 31 DECEMBER 2024
    Go to the press release

  • TURNOVER AT 31 DECEMBER 2024 EQUAL TO 4.2 MILLION EURO, AN INCREASE OF 28.21% COMPARED TO THE SAME PERIOD IN 2023

    TURNOVER AT 31 DECEMBER 2024 EQUAL TO 4.2 MILLION EURO, AN INCREASE OF 28.21% COMPARED TO THE SAME PERIOD IN…
    Go to the press release

  • SALES AS OF SEPTEMBER 30, 2024 AMOUNTS TO APPROXIMATELY 2.8 MILLION EUROS

    SALES AS OF SEPTEMBER 30, 2024 AMOUNTS TO APPROXIMATELY 2.8 MILLION EUROS
    Go to the press release

  • GRANTING OF CONCESSIONS

    GRANTING OF CONCESSIONS
    Go to the press release

  • THE BOARD OF DIRECTORS HAS APPROVED THE HALF-YEARLY REPORT AS OF 30 JUNE 2024

    THE BOARD OF DIRECTORS HAS APPROVED THE HALF-YEARLY REPORT AS OF 30 JUNE 2024
    Go to the press release